Arkolith/Insider Trading/DCPH/Form 4

Flynn Daniel Lee

Chief Scientific OfficerDeciphera Pharmaceuticals, Inc. (DCPH) · full profile →Form 4 · filed Jun 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24K
Net Open-Market Flow
-$24K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2023Sell(S)2K$14.40$24K57K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-038753) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML